We’re pioneering precision neurology by building the world's leading platform for reliable, accessible, affordable diagnosis and monitoring of neurological diseases.
- Ioannis Tarnanas, Ph.D. - Co-Founder and Chief Scientific Officer (CSO)
Active digital biomarkers provide a new understanding of neurocognitive function.
Five-year study on Altoida's simulation of ADL's to predict Alzheimer's conversions.
Dr. Tarnanas presents Altoida at TedX in Zurich; goes on to win EIT Innovators Award 2018.
Four-year study validating Altoida's 94% diagnostic accuracy for AD.
Critical publication shows Altoida is the most sensitive measurement device.
Altoida's Breakthrough designation pioneers Precision Neurology.
Revolutionizing Brain Health
Proud to be working with:
Join the Revolution
Discover Your Path to Better Brain Health